{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:16:46Z","timestamp":1768087006327,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministry of Health of the Czech Republic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.brachy.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T08:47:08Z","timestamp":1680425228000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years"],"prefix":"10.1016","volume":"22","author":[{"given":"Lubo\u0161","family":"Tu\u010dek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5972-3866","authenticated-orcid":false,"given":"Igor","family":"Sir\u00e1k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav","family":"Hodek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ka\u0161aov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-1344","authenticated-orcid":false,"given":"Jakub","family":"Grepl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0285-3800","authenticated-orcid":false,"given":"Petr","family":"Paluska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denisa","family":"Pohankov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1970-621X","authenticated-orcid":false,"given":"Libor","family":"Hru\u0161ka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6497-7505","authenticated-orcid":false,"given":"Milan","family":"Vo\u0161mik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Petera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl S2","key":"10.1016\/j.brachy.2023.02.001_bib0001","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1017\/S0022215116000499","article-title":"Oral cavity and lip cancer: United Kingdom National multidisciplinary guidelines","volume":"130","author":"Kerawala","year":"2016","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.brachy.2023.02.001_bib0002","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2009.01.005","article-title":"GEC-ESTRO recommendations for brachytherapy for head and neck squamous cell carcinomas","volume":"91","author":"Mazeron","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.02.001_bib0003","series-title":"The GEC-ESTRO Handbook of Brachytherapy","first-page":"95","article-title":"Radiobiology of brachytherapy and the dose rate effect","author":"Mazeron","year":"2002"},{"key":"10.1016\/j.brachy.2023.02.001_bib0004","series-title":"Praktisches Handbuch der Brachytherapie","author":"Strnad","year":"2010"},{"key":"10.1016\/j.brachy.2023.02.001_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00405-014-3332-8","article-title":"The role of brachytherapy in the treatment of squamous cell carcinoma of the head and neck","volume":"273","author":"Wierzbicka","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.brachy.2023.02.001_bib0006","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0360-3016(01)01567-X","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma","volume":"50","author":"Nag","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.02.001_bib0007","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.brachy.2013.05.007","article-title":"From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: equivalent results but fewer complications","volume":"12","author":"Guinot","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.001_bib0008","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ijrobp.2011.09.038","article-title":"High dose-rate versus low dose-rate brachytherapy for lip cancer","volume":"83","author":"Ghadjar","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2023.02.001_bib0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1507-1367(05)71093-2","article-title":"Results of interstitial HDR brachytherapy for cancer of the lower lip","volume":"10","author":"Lebioda","year":"2005","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.brachy.2023.02.001_bib0010","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/hed.23529","article-title":"Prognostic factors in squamous cell lip carcinoma treated with high-dose-rate brachytherapy","volume":"36","author":"Guinot","year":"2014","journal-title":"Head and Neck"},{"key":"10.1016\/j.brachy.2023.02.001_bib0011","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(03)00271-8","article-title":"Lip cancer treatment with high dose rate brachytherapy","volume":"69","author":"Guinot","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2023.02.001_bib0012","unstructured":"National Comprehensive Cancer Network: NCCN Guidelines Version 2. 2022 Head and Neck Cancers 2, Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed date 21 September 2022."},{"key":"10.1016\/j.brachy.2023.02.001_bib0013","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1445-2197.2003.t01-1-02710.x","article-title":"Squamous cell carcinoma of the lip: is there a role for adjuvant radiotherapy in improving local control following incomplete or inadequate excision?","volume":"73","author":"Babington","year":"2003","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.brachy.2023.02.001_bib0014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5114\/jcb.2019.84687","article-title":"Adjuvant interstitial three-dimensional pulse-dose-rate brachytherapy for lip squamous cell carcinoma after surgical resection","volume":"11","author":"Chyrek","year":"2019","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2023.02.001_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brachy.2014.08.050","article-title":"High-dose-rate brachytherapy in early oral cancer with close or positive margins","volume":"14","author":"Petera","year":"2015","journal-title":"Brachytherapy"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472123000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:18:24Z","timestamp":1761531504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472123000077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1538472123000077"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2023.02.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}